Defining Patient-Specific Risk in Acute Myeloid Leukemia

[1] Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461) [J]. BLOOD, 2002, 100 (13) : 4325 - 4336

[2] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) : 4642 - 4649

[3] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J]. BLOOD, 2010, 115 (03) : 453 - 474

[4] Dohner H, 2011, HEMATOL-AM SOC HEMAT, V2011, P36

[5] The myth of the second remission of acute leukemia in the adult [J]. BLOOD, 2013, 121 (07) : 1077 - 1082

[6] Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) [J]. BLOOD, 2013, 121 (23) : 4769 - 4777

[7] Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials [J]. BLOOD, 2010, 116 (03) : 354 - 365

[8] Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia [J]. BLOOD, 2013, 121 (12) : 2213 - 2223

[9] Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (09) : 1172 - 1181

[10] Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group [J]. BLOOD, 2012, 120 (08) : 1581 - 1588

[1] Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461) [J]. BLOOD, 2002, 100 (13) : 4325 - 4336

[2] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) : 4642 - 4649

[3] Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J]. BLOOD, 2010, 115 (03) : 453 - 474

[4] Dohner H, 2011, HEMATOL-AM SOC HEMAT, V2011, P36

[5] The myth of the second remission of acute leukemia in the adult [J]. BLOOD, 2013, 121 (07) : 1077 - 1082

[6] Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) [J]. BLOOD, 2013, 121 (23) : 4769 - 4777

[7] Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials [J]. BLOOD, 2010, 116 (03) : 354 - 365

[8] Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia [J]. BLOOD, 2013, 121 (12) : 2213 - 2223

[9] Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (09) : 1172 - 1181

[10] Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group [J]. BLOOD, 2012, 120 (08) : 1581 - 1588